WILMINGTON, NC (WWAY) — AAIPharma/CML plans to expand operations in Wilmington and add jobs over the next few years, according to a news release.
The contract drug development and manufacturing provider will invest $15.8 million in expanded lab operations and corporate headquarters space in Wilmington over the coming three years, Gov. Pat McCrory announced today. The move is expected to bring at least 37 new jobs over the coming three years with a total of 50 jobs and $20 million in new investment anticipated by the end of the project in 2019.
AAIPharma/CML has operated in Wilmington for 30 years, the company said.It currently employs nearly 400 workers at three sites here.
The company’s work includes pharmaceutical development, as well analytical and manufacturing services for every stage of drug development. The company has a global workforce of about 830 at sites in Wilmington, Durham, Missouri, New Jersey, South Carolina, Wisconsin and The Netherlands. Its company-wide workforce totals about 830.
“We appreciate this opportunity to work with city, state and county governments to bring more jobs to the Wilmington area and contribute to the growth of life sciences in the area,” said Stephan Kutzer, CEO, President and Chairman of AAIPharma Services/Cambridge Major Laboratories, said in a statement.
In its announcement, the company said once complete, AAIPharma/CML’s expanded presence is expected to add $16.8 million to Greater Wilmington’s gross domestic product (GDP), according to an economic impact assessment by UNC Wilmington’s Swain Center for Business and Economic Services.